🌟 Our DLBCL case discussion with Sairah Ahmed, MD, and Elif Yilmaz, MD is now available to watch on YouTube!

⮕ Watch the full session: youtu.be/EMPaDlO5lto

#DLBCL #HemeHub #Lymphoma #Hematology #HemOnc #Oncology

@rdm.ox.ac.uk @medsci.ox.ac.uk @ox.ac.uk @bloodjournals.hematology.org #haematology #hematology #cancerresearch #bloodcancer 🧬

🎯Today’s questions!

Swipe to see the answers and explanations!

#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #ClinicalHematology #Genomics #HemeHub

🩸 Facts about Smoldering Multiple Myeloma:

Key SMM risk models include Mayo 2008, PETHEMA, IMWG 20/2/20, cytogenetic risk refinement, and the MGUS-like phenotype.

#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #HemeHub

🌟 Registration for the HemeHub Hematology Summit is filling quickly!

🗓️ October 3, 2026
📍 Gaylord Texan Resort & Convention Center

Registration: hemehub.org/events/hemeh...

#HemeHub #HemeOnc #Hematology #HematologySummit #MedicalEducation #Oncology

Happening next Friday!

⮕ Register: hemehub.org/live-webinars

#SmolderingMyeloma #MultipleMyeloma #Myeloma #Hematology #HemOnc #Oncology #MedicalEducation #MedEd #HemeHub

Get board-ready with the ASH Hematology Review Series (HRS), a comprehensive review designed to support your exam preparation. Enroll today and take your exam with confidence: https://ow.ly/2jWk50ZMKuW

#ABIM #Hematology #MedicalEducation #MedEd #BoardExamsPrep #ASHTrainee

Phase 1 data show that dibotatug produced a 60% overall response rate with a favorable safety profile in large granular lymphocytic leukemia. @societyofhemonc.bsky.social #SOHO2026 #leusm #hematology

www.onclive.com/view/dibotat...

The ASC4FIRST trial continued to show higher molecular response rates and better tolerability with asciminib than with standard TKIs in Ph-positive CML. @societyofhemonc.bsky.social #SOHO2026 #leusm #hematology

www.onclive.com/view/ascimin...

📈MPN expert, Andrew Kuykendall, MD, of Moffitt Cancer Center, ranked these headlining novel treatments in MPNs at #SOHO2026.

‼️Visit our site for more: www.onclive.com/conference/s...

@societyofhemonc.bsky.social #mpnsm #oncology #hematology #cancer

Time-limited pirtobrutinib plus venetoclax and obinutuzumab produced high rates of U-MRD in CLL/SLL. #leusm #hematology

See our site for the full story from PIVOT-CLL, as presented by
@nitinjainmd.bsky.social at #SOHO2026! @societyofhemonc.bsky.social

www.onclive.com/view/time-li...

How to win in #Oncology and #Hematology in 2025

📥 Get a FREE #LucidQuest Report http://dlvr.it/TVQsSS

🚀 Oncp/hema drug development is evolving fast. AI-driven Dx, novel MoAs & outcomes-based pricing are reshaping the landscape.

🏆 Who’s leading? AbbVie, Amgen, AZ, BMS, J&J & Novartis.

ELVN-001 produced molecular responses in previously treated CP-CML according to updated data from the phase 1 ENABLE trial. @societyofhemonc.bsky.social #leusm #hematology

See our site for the full story, as presented at #SOHO2026! www.onclive.com/view/elvn-00...

📈 The ACTIVE regimen yielded responses in heavily pretreated, relapsed or refractory NPM1-mutated AML, according to findings presented at #SOHO2026. @societyofhemonc.bsky.social #leusm #hematology

See the full story from the retrospective study on our site ➡️: www.onclive.com/view/active-...

❓How did selcodebart perform in anemia-defined cohorts of patients with myelofibrosis?

See our site for the data readout of the RALLY-MF trial presented at #SOHO2026! @societyofhemonc.bsky.social #mpnsm #hematology

www.onclive.com/view/selcode...

⚛️ In myelofibrosis diagnosis, determining if underlying disease is proliferative or cytopenic can help guide prognosis and treatment decision-making. #hematology #oncology

Read more insights from Gabriela Hobbs, MD, on our site ➡️: www.onclive.com/view/differe...

🚀💡Today’s questions!

Swipe to see the answers and explanations!

#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #ClinicalHematology #HemeHub #Daratumumab #AQUILA #CENTAURUS

🩸 Facts about Smoldering Multiple Myeloma:

SLIM-CRAB criteria, precursor stages, immunoparesis, evolving biomarkers, and circulating tumor cells all play a role in assessing SMM progression risk.

#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #HemeHub

We're excited for tomorrow's Breakthroughs in Hematology seminar featuring Anand Padmanabhan, MD, Professor and Clinician-Investigator at Mayo Clinic.

Looking forward to a fascinating discussion on the latest advances in thrombosis and hematology research. 🩸🔬

#Hematology #StanfordMedicine

2️⃣ conferences at once! Get ready for #SOHO2026 in Houston and #WCLC26 in Seoul!
🤠 Over the next few days, we’ll be covering the two conferences in-depth with expert insight all on our site! 🇰🇷
@societyofhemonc.bsky.social @iaslc.bsky.social #lcsm #leusm #mmsm #mpnsm #lymsm #oncology #hematology